Unum Therapeutics Inc. | 200 Cambridge Park Drive Suite 3100 | Cambridge, MA 02140  USA

Tel. +1.617.945.5576 | Email: info@unumrx.com

  • LinkedIn - White Circle
  • Twitter - White Circle

© Copyright 2014-2019 Unum Therapeutics

Unum’s leadership possesses biotech and large pharma drug development experience and deep scientific expertise in cancer immunotherapy.



Charles "Chuck" Wilson, PhD

Chief Executive Officer



Seth Ettenberg, PhD

Chief Scientific Officer



Geoffrey Hodge

Chief Technical Officer



Michael Vasconcelles, MD

Chief Medical Officer


Jessica Sachs
Chief Medical Officer


Dr. Sachs has over 16 years of experience in oncology and pediatrics, including a decade in industry. Prior to assuming the role of Chief Medical Officer at Unum, she served as Vice President of Clinical Sciences at Unum, responsible for the clinical development strategy and medical and translational oversight of the Unum portfolio. Before joining Unum, Dr. Sachs spent several years at Takeda/Millennium where she led multiple clinical programs in oncology and transplantation, and at Genzyme Corporation, where she was responsible for post-marketing safety surveillance and risk management activities for a variety of oncology products. Dr. Sachs has been a faculty member of the Harvard Medical School since 2007 and is an Assistant in Pediatrics in the Division of Pediatric Hematology/Oncology at the Massachusetts General Hospital. She completed her fellowship in pediatric hematology and oncology at the Dana Farber Cancer Institute and Children’s Hospital Boston. She received her M.D. from Washington University in St. Louis and her B.S. from Duke University.